Auditors for FDA-regulated businesses
We have a range of auditors available to help FDA-regulated industries comply with best practices and uncover problem areas.
Value of Auditing:
- avert recalls or reduce scope of recalls
- reduce/eliminate errors and omissions
- insure supplier quality
- insure patient safety
- protect your brand’s equity
Types of Auditors
GCP Auditors provide third-party verification that good clinical practices (GCP) are followed. GCP is an international quality standard that is provided by International Conference on Harmonisation (ICH) to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner. GCP guidelines include protection of human rights for the subjects and volunteers in a clinical trial.
GMP Auditors provide third-party verification that good manufacturing practices (GMP) are followed. These practices insure that products are manufactured consistently to an expected level of quality. They are also required in order to conform to regulatory agency recommended guidelines. Agencies such as FDA control authorization and licensing for manufacture and sale of food, pharmaceutical, nutraceutical, cosmeceutical and medical devices. GMP guidelines provide minimum requirements that a manufacturer must meet to assure that the products are of high quality and do not pose any risk to the consumer or public.
HACCP Auditors examine, question, evaluate and report on your safety system’s adequacy and deficiencies. The HACCP Auditor analyzes all elements of the system and reports on how well it adheres to the criteria for management and control of process safety. To do this, they know the standards and principles of auditing a HACCP-based (or process-safety) system.
Pharmacovigilance Auditors provide third-party verification that systems and documentation are in place and consistently followed to insure drug safety, protect your patients and meet regulatory requirements. Third- party audits also provide an opportunity to uncover issues in advance of formal regulatory inspections, which can lead to warning letters.